Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study on doxorubicin kinetic distribution during arterial chemoembolization
2018-002163-26Phase 4Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Jun 2018
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of doxorubicin in hepatocellular carcinoma (HCC), sponsored by Strasbourg University Hospital. Primary endpoint: Histological analysis of intratumoral doxorubicin distribution. Started Jun 2018; status: completed.
02
Drugs
doxorubicin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on 2018-002163-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002163-26.